Accretion Pharmaceuticals Limited engages in the manufacturing and marketing of pharmaceutical products in India. The company offers antibiotic, antibacterial, antifungal, anti-inflammatory, anti-spasmodic, antihistamine, antiallergy, anticough, anticold, antiulcer, gastrointestinal, antacid, anti-diabetic, cardiac, anti-hypertensive, psychotropic, memory enhancer, vitamins, supplements, and other products. It also provides external preparation, oral powder, effervescent formulation, and nutraceutical products, as well as formulations for brain and memory care, neuron care, UTI care, cardiac care, liver care, protein supplement, pediatric care, GIT care, joint and bone care, immunity booster, gynec care, hair and skin care, nail care, and infertility, and PCOS care. The company offers its products in the form of tablets, capsules, oral liquid, ointment, cream, gel, lotion, medicated shampoo, mouthwash, dusting powder, sachet, and dry syrup through contract manufacturing and direct sale
| Current Price | ₹157.00 |
|---|---|
| Market Cap | ₹173 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Medicinal Chemicals and Botanical Products; Pharmaceutical Products; Anti-infective Drugs; Antibiotics; Antifungal Drugs; Antiviral Drugs; Cardiovascular Drugs; Central Nervous System Drugs; Gastrointestinal Drugs |
| P/E Ratio | 17.4 |
| Beta (1Y) | 0.38 |
Accretion Pharmaceuticals Limited is trading at ₹157.00, with a market capitalisation of ₹173 Cr.
Accretion Pharmaceuticals Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Medicinal Chemicals and Botanical Products; Pharmaceutical Products; Anti-infective Drugs; Antibiotics; Antifungal Drugs; Antiviral Drugs; Cardiovascular Drugs; Central Nervous System Drugs; Gastrointestinal Drugs).
Accretion Pharmaceuticals Limited has a P/E of 17.4.